Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
As of September 2025, Novo Nordisk has filed 140 lawsuits and issued 1K cease-and-desist letters against GLP-1 compounders
The new dose is 7.2 milligrams per weekly injection, compared to the original 2.4 milligrams per week
Lameire 2011
According to the FDA label, semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or prior serious hypersensitivity to semaglutide
Diabetes, Other Risk Factors, and 12-yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Reed A, et al
US$ 21.33
US$ 23.93
US$ 26.93
